Little to learn from phase II trials in small-cell lung cancer

Leyvraz,  S.; Stupp,  R.

doi:10.1023/A:1008306930860

Little to learn from phase II trials in small-cell lung cancer

Détails

Télécharger: REF.pdf (290.55 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.

ID Serval

serval:BIB_7DF649A5DD8C

Type

Article: article d'un périodique ou d'un magazine.

Sous-type

Editorial

Collection

Publications

Institution

UNIL/CHUV

Titre

Little to learn from phase II trials in small-cell lung cancer

Périodique

Annals of Oncology

Auteur⸱e⸱s

Leyvraz S., Stupp R.

ISSN

0923-7534 (Print)

Statut éditorial

Publié

Date de publication

09/1999

Volume

10

Numéro

9

Pages

1007-9

Notes

Comment
Editorial --- Old month value: Sep

Mots-clé

Antineoplastic Combined Chemotherapy Protocols/therapeutic use Carcinoma, Small Cell/*drug therapy/mortality/radiotherapy Clinical Trials, Phase II Combined Modality Therapy Hematopoietic Cell Growth Factors/therapeutic use Humans Lung Neoplasms/*drug therapy/mortality/radiotherapy Randomized Controlled Trials Recurrence Survival Rate

URN

urn:nbn:ch:serval-BIB_7DF649A5DD8C6

OAI-PMH

oai:serval.unil.ch:BIB_7DF649A5DD8C

DOI

10.1023/A:1008306930860

Pubmed

10572597

Web of science

000082775000005

Open Access

Oui